Molecular Pharmacology Program

The Daniel Heller Lab

Research

Daniel Heller, PhD
Daniel A. Heller, PhD

Cancer Nanomedicine Laboratory

We are a biomedical engineering laboratory that develops nanotechnologies to advance breakthroughs in the research, diagnosis, and treatment of cancer and allied diseases. We develop drug delivery technologies to target therapies to disease sites, advanced diagnostics to detect disease at earlier stages, and nanosensors to accelerate the discovery of new therapies. Please check out our recent innovations using the “View Lab Overview” button below…

View Lab Overview

Research Projects

Publications

View All Publications

People

Daniel Heller, PhD

Daniel A. Heller, PhD

  • Biomedical engineer Daniel Heller is Head of the Cancer Nanotechnology Laboratory, which invents disruptive technologies to revolutionize the diagnosis and treatment of cancer and allied diseases.
  • PhD, University of Illinois at Urbana-Champaign
[email protected]
Email Address
646-888-3419
Office Phone
Download CV
PDF File

Members

Daniel A. Heller, PhD
Daniel A. Heller

Lab Head

Merav Antman-Passig
Merav Antman-Passig

Postdoctoral Research Fellow

Philip Asamani
Philip Asamani

Graduate Student, CUNY Chemistry PhD Program

Naxhije Berisha
Naxhije Berisha

CUNY Chemistry/Nanotechnology PhD Program Student

Chen Chen
Chen Chen

Tri-institutional PhD Program in Chemical Biology

Dana Goerzen

Graduate Student, Weill Cornell PBSB PhD Program

Declan Gwynne
Declan Gwynne

Senior Research Technician

Takeshi Irie
Takeshi Irie

Assistant Attending, Anesthesiology and Critical Care

Arianna Izawa-Ishiguro
Arianna Izawa-Ishiguro

Graduate Student

Erin Keblish
Erin Keblish

Graduate Student, Weill Cornell PBSB PhD Program

Mijin Kim
Mijin Kim

Postdoctoral Research Associate

Quincey LaPlant
Quincey LaPlant

Assistant Attending L1, Radiation Oncology

Magdalini Panagiotakopoulos
Magdalini Panagiotakopoulos

Postdoctoral Research Associate

Ewelina Randall

Undergraduate Researcher

Raashed Raziuddin

Graduate Student, Weill Cornell Pharmacology PhD Program

Stephen Ruiz
Stephen Ruiz

BCMB PhD Program Student

Janki Shah
Janki Shah

Lab Manager

Ramya Sridharan
Ramya Sridharan

PhD Pharmacology Program Weill Cornell, Memorial Sloan Kettering Cancer Center

Ashley Sullivan

MSK Bridge Program Scholar

Daniel Tylawsky
Daniel Tylawsky

Graduate Student (Weill Cornell Medicine; Pharmacology PhD Program)

Kristen Vogt
Kristen Vogt

Tri-institutional PhD Program in Chemical Biology

Laura Wilson
Laura Wilson

Senior SKI Administrative Assistant

Lab Alumni
Cynthia Almonte
Cynthia Almonte

Clinical Nurse

Elana Apfelbaum
Elana Apfelbaum

Graduate Student, Weill Cornell Pharmacology PhD Program

Hanan Baker
Hanan Baker

Resident in Anesthesiology, Bonica Scholars Program, University of Washington

Gavin Black
Gavin Black

Associate Consultant, Triangle Insights Group, LLC

Januka Budhathoki-Uprety, PhD
Januka Budhathoki-Uprety

Assistant Professor, North Carolina State University

Christian Cupo
Christian Cupo

Research Technician

Ron Feiner
Ron Feiner

Equity Research Associate - Medical Devices at Oppenheimer & Co. Inc

Rune  Frederiksen
Rune Frederiksen

Research Fellow

Thomas Galassi
Thomas Galassi

Managing Director, Investor Communications at LifeSci Advisors LLC

Emma Grabarnik
Emma Grabarnik

Scientist I, Nanotechnology Characterization Laboratory, National Cancer Institute, National Institutes of Health

Jackson Harvey
Jackson Harvey

Analyst, Deerfield

Christopher Horoszko
Christopher Horoszko

Postdoctoral Research Fellow

Prakrit Jena, PhD
Prakrit Jena

CTO, Lime Therapeutics, Inc.

Brian J. Joseph
Brian J. Joseph

Healey ALS Scholar at Columbia University Irving Medical Center

Hiro Kiguchi
Hiro Kiguchi

Attending Physician, Division of Oncology,  Children's Hospital of Philadelphia

Jaclyn Kubala
Jaclyn Kubala

Scientist I, SalioGen Therapeutics

Pictured: Rachel Langenbacher
Rachel Langenbacher

Associate Medical Writer – PPD

Mandana T. Manzari
Mandana T. Manzari

Business Development at Resilience

Daniel Roxbury
Daniel Roxbury

Associate Professor, University of Rhode Island

Yosef Shamay
Yosef Shamay

Assistant Professor, Faculty of Biomedical Engineering, Technion-Israel Institute of Technology

Maria Sirenko

Graduate Student, GSK PhD Program

Jasmine Wallas
Jas Wallas

Patent Agent at Smith Baluch LLP

Ryan Williams, PhD
Ryan Williams
Zvi Yaari, PhD
Zvi Yaari

Assistant Professor, School of Pharmacy, Department of Medicine, Hebrew University of Jerusalem, Israel

Lab Affiliations

Achievements

  • American Institute for Medical and Biological Engineering (AIMBE) Fellow (2021)
  • Pharmacology Teaching and Mentoring Award, Weill Cornell Graduate School (2020)
  • American Cancer Society Research Scholar (2018)
  • NSF CAREER Award (2018)
  • Pershing Square Sohn Prize for Young Innovators in Cancer Research (2017)
Read more
  • NIH Director’s New Innovator Award (2012)
  • Damon Runyon Cancer Research Foundation Postdoctoral Fellowship (2010)
  • Beckman Institute Graduate Fellowship (2006)

Lab News & Events

Accolades

Team Recognitions

  • Congratulations to Dr. Mijin Kim - NIH K99/R00 awardee!
  • Congratulations to Naxhije Berisha - Tow Fellowship Awardee!
  • Congratulations to Dr. Mijin Kim - Kravis WiSE Postdoctoral Fellowship Winner!
  • Congratulations to Stephen Ruiz - awarded the MERIT Mandel Graduate Fellowship!
  • Congratulations to Magdalini Panagiotakopoulos – Tow Postdoctoral Fellowship Awardee!
  • Congratulations to Dr. Mijin Kim – MIT Technology Review 35 Under 35 Innovator!
  • Congratulations to Magdalini Panagiotakopoulos on winning the Controlled Release Society Poster Prize

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Daniel A. Heller discloses the following relationships and financial interests:

  • Concarlo Holdings, LLC
    Provision of Services
  • Goldilocks Therapeutics Inc.
    Fiduciary Role/Position; Ownership / Equity Interests; Provision of Services
  • Lime Therapeutics, Inc.
    Fiduciary Role/Position; Ownership / Equity Interests; Provision of Services (uncompensated)
  • Mediphage Bioceuticals, Inc.
    Ownership / Equity Interests; Provision of Services (uncompensated)
  • Nanorobotics, Inc.
    Ownership / Equity Interests
  • Nirova BioSense, Inc.
    Ownership / Equity Interests
  • Resident Diagnostics, Inc.
    Ownership / Equity Interests; Provision of Services (uncompensated)

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures